Abstract:To analyze the treatment effect of the curcumin nanoparticle drug delivery system to the Alzheimer’s disease (AD), the NP-Cur, NP-S1-Cur, and NP-S1-Cur-CRT nanoparticles were prepared by combining the various internal water phases based on the emulsification volatilization method for the cytotoxicity test and applied to treatment of β-amyloid precursor protein/pistilloid-stamen 1 (APP/PS1) double transgenic (DT) mice in three groups, which were group W1 (treated with NP-Cur), W2 (treated with NP-S1-Cur), W3 (treated with NP-S1-Cur-CRT), W4 (treated with curcumin drugs), and W0 (normal control), respectively. Immunohistochemistry was adopted to detect the senile plaques (amyloid precursor antibody, 6E10), microglia (IBA-1), and astrocytes (glial fibrillary acidic protein, GFAP). The spatial memory ability (SMA) of mice was evaluated by the Y maze experiment, and the learning memory ability (LMA) of mice was evaluated by the new thing cognition experiment. The results showed that in the human neuroblastoma cell (SH-SY5Y), mouse brain microvascular endothelial cell line (bEnd.3), and mouse microglia cell line (BV2), the cell activity (CA) caused by NP-Cur, NP-S1-Cur, and NP-S1-Cur-CRT nanoparticles all decreased with the increase of concentration value of curcumin, but all were higher than 80%; it was found based on the Y maze experiment that the stay time (ST) and the number of entries (NE) in the group W4 were higher than those in group W1, W2, and W3 (P < 0.05); the frequency of exploring new things in the group W0 was higher than the frequency in W1, W2, and W3 (P < 0.05). There was no remarkable difference in the exploration frequency of new things in group W4 and W0 (P > 0.05); the positive units (PU values) of cytoplasm and nucleus (C&N) 6E10 protein in W4 were lower than the values in W1, W2, and W3 (P > 0.05); the PU value of C&N IBA-1 protein of W4 was lower than the value in W1, W2, and W3 (P < 0.05); the PU value of C&N GFAP protein expression in group W4 was lower obviously than the value in W1, W2, and W3 (P < 0.05). In short, poly lactic-co-glycolic acid (PLGA) nanoparticles loaded with curcumin had good biosafety and compatibility. It can effectively improve the LMA of APP/PS1 mice, reduce the area of senile plaques, and have better neuroprotective function. Among them, the NP-S1-Cur-CRT nanoparticles had the best improvement effect.

Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats

Curcumin Improves Amyloid Β-Peptide (1-42) Induced Spatial Memory Deficits Through BDNF-ERK Signaling Pathway

Curcumin Attenuates Lipopolysaccharide-Induced Neuroinflammation and Memory Deficiency by Inhibiting Microglia Activation in Mice Hippocampus

The impacts of curcumin on learning memory function in Alzheimer’s disease under the poly lactic-co-glycolic acid nanoparticle drug carrier

Curcumin Mitigates the High-Fat High-Sugar Diet-Induced Impairment of Spatial Memory, Hepatic Metabolism, and the Alteration of the Gut Microbiome in Alzheimer's Disease-Induced (3xTg-AD) Mice

Curcumin Ameliorates Memory Deficits by Enhancing Lactate Content and MCT2 Expression in APP/PS1 Transgenic Mouse Model of Alzheimer's Disease

Curcumin alleviates Alzheimer's disease by inhibiting inflammatory response, oxidative stress and activating the AMPK pathway

Chemokine CCL2 impairs spatial memory and cognition in rats via influencing inflammation, glutamate metabolism and apoptosis-associated genes expression- a potential mechanism for HIV-associated neurocognitive disorder

HIV‐1 Inhibits Long‐term Potentiation and Attenuates Spatial Learning

Curcuma treatment prevents cognitive deficit and alteration of neuronal morphology in the limbic system of aging rats

Curcumin intervention in hippocampal atrophy of diet-induced Alzheimer-like deficits in insulin-resistant rats

Curcumin alleviates neuroinflammation, enhances hippocampal neurogenesis, and improves spatial memory after traumatic brain injury

Curcumin rescues aging-related loss of hippocampal synapse input specificity of long term potentiation in mice

Curcumin Exerts Effects on the Pathophysiology of Alzheimer's Disease by Regulating PI(3,5)P2 and Transient Receptor Potential Mucolipin-1 Expression.

Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats

Effects of Curcumin on neuronal apoptosis and neurobehavioral outcomes in rats after global cerebral ischemic and reperfusion injury

NMDA receptor antagonists engender neuroprotection against gp120-induced cognitive dysfunction in rats through modulation of PKR activation, oxidative stress, ER stress and IRE1α signal pathway

Curcumin Derivative Cur20 Attenuated Cerebral Ischemic Injury by Antioxidant Effect and HIF-1α/VEGF/TFEB-Activated Angiogenesis

Nanocurcumin prevents memory impairment, hippocampal apoptosis, Akt and CaMKII-α signaling disruption in the central STZ model of Alzheimer's disease in rat

Neuroprotective Potential of Indian Propolis and in Combination with Curcumin against Bilateral Common Carotid Artery Occlusion Induced Vascular Dementia in Rats

Relationship between Amelioration of Curcumin on Learning and Memory Ability and the Contents of NO、SOD、MDA and ChAT in Brain of AD Rats